Ergoteles LLC Vaxart, Inc. Transaction History

Ergoteles LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 10, 2023	SELL	$0.71 - $1.25 $619,018 - $1.09 Million	-871,857 Reduced 83.78%	168,791 $128,000
Q4 2022 Feb 14, 2023	BUY	$0.75 - $2.24 $780,486 - $2.33 Million	1,040,648 New	1,040,648 $999,000
Q1 2022 May 13, 2022	SELL	$4.29 - $6.64 $624,542 - $966,657	-145,581 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$5.77 - $7.96 $840,002 - $1.16 Million	145,581 New	145,581 $913,000

110

37.6M

188K

180K

Ticker VXRT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 126,506,000
Market Cap $73.4M
Description
Vaxart, Inc., a clinical-stage biotechnology company, engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, an oral tablet vaccine, which is in a Phase Ib clinical trial with bivalent oral tablet vaccine for the GI.1...

Get notified when there are updates to the investment portfolio of Ergoteles LLC, based on Form 13F filings with the SEC.

Stay updated on Ergoteles LLC with notifications on news.